Management of Prediabetes
Adults with prediabetes should be referred to an intensive lifestyle behavior change program targeting at least 7% weight loss and 150 minutes weekly of moderate-intensity physical activity, with metformin added for those with BMI ≥35 kg/m², age <60 years, fasting glucose ≥110 mg/dL, A1C ≥6.0%, or prior gestational diabetes. 1
Lifestyle Intervention: The Foundation
The Diabetes Prevention Program (DPP) provides the strongest evidence for diabetes prevention in the U.S., demonstrating a 58% reduction in diabetes incidence over 3 years with intensive lifestyle intervention—far superior to any pharmacologic approach. 1 Long-term follow-up confirms durability: 39% risk reduction at 30 years (Da Qing study), 43% at 7 years (Finnish DPS), and 27% at 15 years (DPPOS). 1
Weight Loss Goals
- Target minimum 7% body weight reduction from baseline, achieved through calorie restriction of 500-1,000 calories daily below maintenance needs. 1, 2
- Weight loss of 7-10% provides even greater benefit for diabetes prevention. 1
- Aim for 1-2 pounds per week weight loss rate. 1, 2
- Initial focus can be on reducing total dietary fat, then transition to comprehensive calorie and fat restriction after several weeks. 1
Physical Activity Requirements
- Prescribe at least 150 minutes per week of moderate-intensity aerobic activity (equivalent to brisk walking), distributed over at least 3 days with no more than 2 consecutive days without exercise. 1, 2, 3
- Each session should last at least 10 minutes. 1
- Up to 75 minutes of strength training can count toward the 150-minute weekly goal. 1
- This activity level approximates 700 kcal/week energy expenditure. 1
Dietary Patterns
Multiple eating patterns are effective for diabetes prevention—choose based on patient preference and cultural context. 1 Evidence supports: 1, 4
- Mediterranean-style diet 1, 4
- Low-carbohydrate eating plans 1
- Vegetarian or plant-based diets (may include some animal products) 1, 4
- DASH (Dietary Approaches to Stop Hypertension) 1, 4
- Intermittent fasting 1
All patterns should emphasize whole grains, legumes, nuts, fruits, and vegetables while minimizing refined and processed foods. 1, 4 Eliminate or drastically reduce sugar-sweetened beverages, refined grains, sweets, and ultraprocessed foods. 2
Structured Program Enrollment
Enroll patients in a CDC-recognized Diabetes Prevention Program or equivalent intensive behavioral counseling program. 2 These structured programs provide: 1
- 16-session core curriculum completed within 24 weeks
- Training in self-monitoring techniques
- Guidance on managing psychological, social, and motivational challenges
- Ongoing support for maintaining healthy behaviors
Technology-assisted programs (smartphone apps, web-based platforms, telehealth) are acceptable alternatives, particularly for patients in rural locations or with access barriers, though not all are equally effective. 1
Medical Nutrition Therapy
Refer all patients with prediabetes to a registered dietitian nutritionist (RDN) for individualized medical nutrition therapy at diagnosis and at regular intervals. 1, 2 Medical nutrition therapy achieves significant reductions in weight, waist circumference, and glycemia. 1, 2
Pharmacologic Intervention
Metformin: First-Line Medication
Consider metformin for patients meeting ANY of these high-risk criteria: 1, 2
- BMI ≥35 kg/m²
- Age 25-59 years (particularly <60 years)
- Fasting plasma glucose ≥110 mg/dL
- A1C ≥6.0%
- History of gestational diabetes mellitus
Metformin reduces diabetes incidence by 31% relative risk reduction and has demonstrated long-term safety. 2, 5 However, it is less effective than intensive lifestyle intervention (31% vs 58% risk reduction). 5
Important caveat: Long-term metformin use may cause vitamin B12 deficiency. 1 Periodically assess vitamin B12 levels, especially in patients with anemia or peripheral neuropathy. 1
Alternative Pharmacologic Options
While metformin has the strongest evidence base, other agents have shown efficacy in specific contexts:
- Pioglitazone may be considered for patients with prior stroke and insulin resistance, but balance this against increased risks of weight gain, edema, and fractures. 1 Lower doses may mitigate adverse effects but reduce efficacy. 1
- GLP-1 receptor agonists can achieve significant weight reduction, particularly in patients with obesity. 6
- Acarbose has demonstrated ability to delay diabetes onset. 7, 8
Vitamin D: Insufficient Evidence
Recent meta-analyses suggest modest potential benefit of vitamin D supplementation in specific populations, but several concerns preclude routine recommendation: 1
- Optimal dosing remains unclear (trials used varying doses higher than recommended daily allowance)
- Benefit-to-risk ratio uncertain for widespread use
- Individual trial results were not statistically significant
- Further research needed to define appropriate patient characteristics
Monitoring and Follow-Up
Glucose Monitoring
- Screen for diabetes progression at least annually using fasting glucose, 2-hour oral glucose tolerance test, or A1C. 6, 2
- For patients on interventions, assess response with A1C every 3 months initially. 6
Cardiovascular Risk Management
Patients with prediabetes have increased cardiovascular disease risk and require aggressive cardiovascular risk factor management. 6, 2
- Target blood pressure <140/90 mmHg. 6
- Initiate statin therapy based on cardiovascular risk assessment. 6
- Consider SGLT2 inhibitors or GLP-1 agonists for cardioprotection in appropriate patients. 6
- Screen for chronic kidney disease, atherosclerotic cardiovascular disease, and heart failure. 6
Comprehensive Metabolic Monitoring
- BMI and blood pressure at each visit 6
- Lipid panel annually 6
- eGFR and comprehensive metabolic panel annually 6
Sleep Assessment
Address sleep quality and duration, as sleep deprivation (<6 hours) or excessive sleep (>9 hours) increases diabetes risk by up to 50%. 4 Target 7 hours of sleep per night, which is associated with lowest diabetes risk. 4
Common Pitfalls to Avoid
Don't rely solely on A1C for diagnosis in patients with hemoglobinopathies or conditions affecting red blood cell turnover—use fasting glucose or oral glucose tolerance testing instead. 1
Don't prescribe metformin without considering high-risk criteria—it's most effective in specific subgroups (younger patients, higher BMI, higher baseline glucose). 1, 2, 5
Don't neglect vitamin B12 monitoring in patients on long-term metformin—deficiency can cause irreversible neurologic complications. 1
Don't offer lifestyle counseling without structured program referral—unstructured advice is far less effective than intensive, goal-based programs with ongoing support. 1, 2
Don't focus exclusively on glucose control while ignoring cardiovascular risk factors—prediabetes increases cardiovascular event rates and mortality. 6, 2, 5